Relmada Therapeutics, Inc.

Events

American Urology Association (AUA2025)

Abstract Overview
Abstract Title:   Prospective Open Label Study to Evaluate the Safety and Efficacy of intravesical sustained release Gemcitabine Docetaxel combination
(NDV-01) in High Risk NMIBC
Session:   Clinical Trials in Progress: Bladder Cancer
Location:   Hall C, The Square, Learning Lab
Presentation Date:   April 28, 2025
Presentation Time   10:04 AM PT to 10:12 AM PT